Mesoporous silica nanoparticles for treating spinal cord injury
暂无分享,去创建一个
[1] P. Couvreur,et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[2] Wolfhard Semmler,et al. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[3] Riyi Shi,et al. Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury , 2010, Journal of Experimental Biology.
[4] Takuro Niidome,et al. PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[5] R. Shi,et al. Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue , 2004, Neurochemistry International.
[6] A. Karydas,et al. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[7] Jianlin Shi,et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.
[8] R. Shi,et al. Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury , 2009, Journal of neurochemistry.
[9] Hiroaki Sai,et al. Ultrasmall sub-10 nm near-infrared fluorescent mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.
[10] R. Shi,et al. Acrolein inflicts axonal membrane disruption and conduction loss in isolated guinea-pig spinal cord , 2002, Neuroscience.
[11] Yaping Li,et al. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.
[12] Laetitia Gonzalez,et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. , 2009, Small.
[13] D. Burke,et al. Incidence rates and populations at risk for spinal cord injury: A regional study , 2001, Spinal Cord.
[14] R. Shi,et al. Accumulation of Acrolein–Protein Adducts after Traumatic Spinal Cord Injury , 2005, Neurochemical Research.
[15] James F. Leary,et al. Biosensor-controlled gene therapy/drug delivery with nanoparticles for nanomedicine , 2005, SPIE BiOS.
[16] E. Niki,et al. Acrolein Is a Product of Lipid Peroxidation Reaction , 1998, The Journal of Biological Chemistry.
[17] R. Shi,et al. Neuroprotection from secondary injury by polyethylene glycol requires its internalization , 2007, Journal of Experimental Biology.
[18] R. Shi,et al. Hydralazine rescues PC12 cells from acrolein‐mediated death , 2006, Journal of neuroscience research.
[19] Raoul Kopelman,et al. Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications. , 2003, Journal of biomedical materials research. Part A.
[20] Zhenkun Zhang,et al. Synthesis of poly(ethylene glycol) (PEG)-grafted colloidal silica particles with improved stability in aqueous solvents. , 2007, Journal of colloid and interface science.
[21] B. Duerstock,et al. Hydralazine inhibits compression and acrolein‐mediated injuries in ex vivo spinal cord , 2007, Journal of neurochemistry.
[22] M. Radomski,et al. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects , 2011, International journal of nanomedicine.
[23] Weihong Tan,et al. Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[24] Libang Feng,et al. Preparation of poly(ethylene glycol)-grafted silica nanoparticles using a facile esterification condensation method , 2009 .
[25] S. Aiba,et al. Synthesis of a chitosan-dendrimer hybrid and its biodegradation. , 2003, Biomacromolecules.
[26] R. Shi,et al. Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune enchephalomyelitis mouse , 2011, Neuroscience.
[27] Qiang Cai,et al. Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium , 2001 .
[28] Michael J Sailor,et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.
[29] R. Shi,et al. Critical role of acrolein in secondary injury following ex vivo spinal cord trauma , 2008, Journal of neurochemistry.
[30] Weihong Tan,et al. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[31] T. Heinonen,et al. Decrease of reduced glutathione in isolated rat hepatocytes caused by acrolein, acrylonitrile, and the thermal degradation products of styrene copolymers. , 1980, Toxicology.
[32] Riyi Shi,et al. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. , 2008, Nanomedicine.
[33] R. Shi,et al. Acrolein‐mediated mechanisms of neuronal death , 2006, Journal of neuroscience research.